Company	Share, %
Lexicon Pharmaceuticals, Inc.	47.74
Scholar Rock Holding Corporation	14.46
GlycoMimetics, Inc.	13.34
Silence Therapeutics plc	10.02
Syros Pharmaceuticals, Inc.	9.47
IGM Biosciences, Inc.	9.31
Seer, Inc.	7.82
Harpoon Therapeutics, Inc.	7.7
Selecta Biosciences, Inc.	5.89
HOOKIPA Pharma Inc.	5.87
AlloVir, Inc.	5.74
SQZ Biotechnologies Company	5.45
Gossamer Bio	5.35
Cyclerion Therapeutics, Inc.	5.13
Vigil Neuroscience, Inc.	4.91
Morphic Holding, Inc.	4.42
Generation Bio Co.	4.23
Kymera Therapeutics, Inc.	4.14
Black Diamond Therapeutics, Inc.	3.96
Ovid Therapeutics Inc.	3.54
Vor Biopharma Inc.	3.44
Selecta Biosciences, Inc.	3.18
ACELYRIN, INC. Common Stock	3.09
Sagimet Biosciences Inc. Series A Common Stock	3.04
Erasca, Inc.	2.72
Solid Biosciences Inc.	2.41
Omega Therapeutics, Inc.	2.4
Adagene Inc.	2.27
Lexeo Therapeutics, Inc.	2.26
Talaris Therapeutics, Inc.	2.17
Ikena Oncology, Inc.	2.07
Wave Life Sciences Ltd.	2.02
Taysha Gene Therapies, Inc.	1.96
TCR2 Therapeutics Inc.	1.91
Achilles Therapeutics plc	1.84
Curis, Inc.	1.78
Foghorn Therapeutics Inc.	1.69
Repare Therapeutics Inc.	1.65
Neumora Therapeutics, Inc. Common Stock	1.61
Xilio Therapeutics, Inc.	1.31
ContraFect Corporation	0.51
Tourmaline Bio, Inc.	0.36
Senti Biosciences, Inc.	0.12